Puma Biotechnology | Koszty Operacyjne



Operating Expenses Zmiana Data
Agios Pharmaceuticals USD 115.35M 20.41M 2025-03
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
Amgen USD 6.86B 85M 2025-03
Biogen USD 2.12B 106.5M 2025-03
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
Daiichi Sankyo JPY 435.08B 11.65B 2025-03
Exelixis USD 368.59M 34.96M 2025-04
Gilead Sciences USD 4.43B 687M 2025-03
Glaxosmithkline GBP 7.42B 408M 2024-12
Incyte USD 847.73M 29.46M 2025-03
MacroGenics USD 35.94M 20.58M 2024-12
Moderna USD 1.16B 1.06B 2025-03
Novartis USD 11.28B 1.73B 2024-12
Pfizer USD 10.05B 8.12B 2025-03
PTC Therapeutics USD 205.87M 69.79M 2025-03
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Sarepta Therapeutics USD 1.05B 548.51M 2025-03
Takeda JPY 1.13T 51.15B 2025-03
TG Therapeutics USD 78.24M 6.79M 2024-12
Ultragenyx Pharmaceutical USD 282.23M 4.92M 2025-03
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



Puma Biotechnology Koszty Operacyjne - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.